Cargando…

Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients

Introductionand Aim. Patients with cirrhosis are often hospitalized repeatedly for a variety of complications. This retrospective study aimed to assess the effects of minimal hepatic encephalopathy (MHE) and Biejia-Ruangan (BR) on first hospital readmission in nonalcoholic cirrhosis patients without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Ting-Ting, Liu, Xiao-Li, Jiang, Yu-Yong, Wang, Xian-Bo, Yang, Zhi-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123979/ https://www.ncbi.nlm.nih.gov/pubmed/34055016 http://dx.doi.org/10.1155/2021/6652858

Ejemplares similares

Compound Biejia-Ruangan tablet as an adjunctive therapy to entecavir for chronic hepatitis B complicated with hepatic fibrosis: A systematic review and meta-analysis of randomized controlled trials
por: Xu, Yong-hong, et al.
Publicado: (2022)

Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis
por: Meng, Xiangbo, et al.
Publicado: (2022)

Effects of novel Fufang Biejia Ruangan Tablets with sheep placenta as substitute for Hominis Placenta on CCl(4)-induced liver fibrosis
por: Shen, Baode, et al.
Publicado: (2021)

Experimental study on effect of Compound Biejia Ruangan prescription on high-resolution computerized tomographic images in bleomycin induced pulmonary fibrosis rats
por: Dong-wei, Zhang, et al.
Publicado: (2003)

Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Rong, Guanghua, et al.
Publicado: (2020)

Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial
por: Qu, Jianhui, et al.
Publicado: (2014)

Effect of Fufang Biejia Ruangan Tablet on lowering biochemical and virological parameters of hepatic fibrosis in patients with chronic hepatitis B: Protocol for a systematic review and meta-analysis of randomized controlled trials and cohort studies
por: Huang, Chaoyuan, et al.
Publicado: (2019)

Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE
por: Wan, Lijun, et al.
Publicado: (2023)

Predictors of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
por: Sharma, Praveen, et al.
Publicado: (2010)

Minimal hepatic encephalopathy and sleep disorders in patients with cirrhosis: Which comes first?
por: Ridola, Lorenzo, et al.
Publicado: (2020)

Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis
por: Khodadoostan, Mahsa, et al.
Publicado: (2018)

Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis
por: Xia, Xiaoxue, et al.
Publicado: (2018)

Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy
por: San Martín-Valenzuela, Constanza, et al.
Publicado: (2020)

Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
por: Moran, Segundo, et al.
Publicado: (2021)

Aberrant inter-hemispheric coordination characterizes the progression of minimal hepatic encephalopathy in patients with HBV-related cirrhosis
por: Ye, Min, et al.
Publicado: (2020)

The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis
por: Zhang, Yuying, et al.
Publicado: (2015)

Minimal Hepatic Encephalopathy in Patients with Cirrhosis by Measuring Liver Stiffness and Hepatic Venous Pressure Gradient
por: Sharma, Praveen, et al.
Publicado: (2012)

Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways
por: Liu, Liming, et al.
Publicado: (2021)

Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis
por: Pusateri, Antoinette, et al.
Publicado: (2023)

Prediction of Minimal Hepatic Encephalopathy
por: Lee, Sangheun, et al.
Publicado: (2012)

Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma
por: Chen, Cuilan, et al.
Publicado: (2022)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
por: Butterworth, Roger F.
Publicado: (2019)

Hepatic encephalopathy due to cardiac cirrhosis
por: Ono, Ryohei, et al.
Publicado: (2023)

Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
por: Sato, Takuro, et al.
Publicado: (2019)

Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy
por: Nardelli, Silvia, et al.
Publicado: (2019)

Changes in dynamic and static brain fluctuation distinguish minimal hepatic encephalopathy and cirrhosis patients and predict the severity of liver damage
por: Ji, Jiang, et al.
Publicado: (2023)

Regulation of Shaoyao Ruangan Mixture on Intestinal Flora in Mice With Primary Liver Cancer
por: Zhen, Hongde, et al.
Publicado: (2019)

Chinese guidelines on management of hepatic encephalopathy in cirrhosis
por: Xu, Xiao-Yuan, et al.
Publicado: (2019)

Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
por: Ecker, Miriam Eva, et al.
Publicado: (2022)

Inhibitory Control Test, Critical Flicker Frequency, and Psychometric Tests in the Diagnosis of Minimal Hepatic Encephalopathy in Cirrhosis
por: Sharma, Praveen, et al.
Publicado: (2013)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

Frequency and predictive factors of minimal hepatic encephalopathy before and after sustained virological response in HCV cirrhosis
por: Piedade, Juliana, et al.
Publicado: (2022)

Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis
por: Yuan, Lan-Ting, et al.
Publicado: (2018)

Thalamic Structural Connectivity Abnormalities in Minimal Hepatic Encephalopathy
por: Chen, Hua-Jun, et al.
Publicado: (2021)

Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Rai, Rahul, et al.
Publicado: (2015)

Profile of Hepatic Encephalopathy in Children with Cirrhosis and Response to Lactulose
por: Sharma, Praveen, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6fnjafiisgq2fker7qs7mejja9